The decrease in platelet count induced by the administration of PMSG and hCG was reversed to the level of the untreated control group by the PAF antagonist, and the inhibitory effect of PAF antagonists on ovulation and thrombocytopenia could be completely prevented by the administration of a synthetic PAF injection. The gene discussed is PCLAF; the disease is Thrombocytopenia.